{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04708171",
            "orgStudyIdInfo": {
                "id": "MEC-2020-081-2"
            },
            "organization": {
                "fullName": "Erasmus Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections",
            "officialTitle": "The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections",
            "acronym": "PROGRAM",
            "therapeuticArea": [
                "Other"
            ],
            "study": "the-program-study-awake-mapping-versus-asleep-mapping-versus-no-mapping-for-glioblastoma-resections"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-01-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-10-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-10-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-11-26",
            "studyFirstSubmitQcDate": "2021-01-11",
            "studyFirstPostDateStruct": {
                "date": "2021-01-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-05-05",
            "lastUpdatePostDateStruct": {
                "date": "2022-05-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Jasper Gerritsen",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Erasmus Medical Center"
            },
            "leadSponsor": {
                "name": "Erasmus Medical Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Medical Center Haaglanden",
                    "class": "OTHER"
                },
                {
                    "name": "Universitaire Ziekenhuizen KU Leuven",
                    "class": "OTHER"
                },
                {
                    "name": "University of California, San Francisco",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The study is designed as an international, multicenter prospective cohort study. Patients with presumed glioblastoma (GBM) in- or near eloquent areas on diagnostic MRI will be selected by neurosurgeons. Patients will be treated following one of three study arms: 1) a craniotomy where the resection boundaries for motor or language functions will be identified by the \"awake\" mapping technique (awake craniotomy, AC); 2) a craniotomy where the resection boundaries for motor functions will be identified by \"asleep\" mapping techniques (MEPs, SSEPs, continuous dynamic mapping); 3) a craniotomy where the resection boundaries will not be identified by any mapping technique (\"no mapping group\"). All patients will receive follow-up according to standard practice."
        },
        "conditionsModule": {
            "conditions": [
                "Glioblastoma"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 453,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Awake mapping under local anesthesia",
                    "interventionNames": [
                        "Procedure: Awake mapping under local anesthesia"
                    ]
                },
                {
                    "label": "Asleep mapping under general anesthesia",
                    "interventionNames": [
                        "Procedure: Asleep mapping under general anesthesia"
                    ]
                },
                {
                    "label": "Resection under general anesthesia without mapping",
                    "interventionNames": [
                        "Procedure: Resection under general anesthesia without mapping"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "PROCEDURE",
                    "name": "Awake mapping under local anesthesia",
                    "description": "During an awake craniotomy, the patient is awake and cooperative during the resection of the tumor while the surgeon uses electro(sub)cortical mapping to prevent damage to eloquent areas.",
                    "armGroupLabels": [
                        "Awake mapping under local anesthesia"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Asleep mapping under general anesthesia",
                    "description": "During asleep mapping under general anesthesia, the surgeon uses electro(sub)cortical mapping with evoked potentials (MEPs, SSEPs or continuous dynamic mapping) to prevent damage to eloquent areas.",
                    "armGroupLabels": [
                        "Asleep mapping under general anesthesia"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Resection under general anesthesia without mapping",
                    "description": "During resection under general anesthesia without mapping, the surgeon does not use any intraoperative stimulation mapping techniques to identify eloquent areas.",
                    "armGroupLabels": [
                        "Resection under general anesthesia without mapping"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Neurological morbidity",
                    "description": "NIHSS deterioration of 1 point or more as compared to baseline value.",
                    "timeFrame": "Between baseline and 6 weeks/3 months/6 months postoperatively"
                },
                {
                    "measure": "Extent of resection",
                    "description": "Resection percentage as assessed by an independent neuroradiologist on MRI contrast images with volumetric analysis",
                    "timeFrame": "Assessed within 72 hours on postoperative MRI scan"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Progression-free survival",
                    "description": "Progression-free survival (PFS) defined as time from diagnosis to disease progression (occurrence of a new tumour lesion with a volume greater than 0.175 cm\u00b3, or an increase in residual tumour volume of more than 25%) or death, whichever comes first.",
                    "timeFrame": "Between surgery and 12 months postoperatively"
                },
                {
                    "measure": "Overall survival",
                    "description": "Overall survival (OS) defined as time from diagnosis to death from any cause.",
                    "timeFrame": "Between surgery and 12 months postoperatively"
                },
                {
                    "measure": "Onco-functional outcome",
                    "description": "2D coordinate based on extent of resection (or residual tumor volume) on the x-axis and NIHSS score on the y-axis",
                    "timeFrame": "Between baseline and 6 weeks/3 months/6 months postoperatively"
                },
                {
                    "measure": "Frequency and severity of Serious Adverse Events (SAEs)",
                    "description": "Infections, intracerebral bleeding, epilepsy, aphasia, paresis/paralysis in arms or/and legs (this is not an exhaustive list).",
                    "timeFrame": "Between surgery and 6 weeks postoperatively"
                },
                {
                    "measure": "Residual tumor volume",
                    "description": "Postoperative tumor volume in mm3 as assessed by an independent neuroradiologist on MRI contrast images with volumetric analysis",
                    "timeFrame": "Assessed within 72 hours on postoperative MRI scan"
                },
                {
                    "measure": "MRC deterioration (for motor gliomas)",
                    "description": "MRC deterioration of 1 point or more as compared to baseline value.",
                    "timeFrame": "Between baseline and 6 weeks/3 months/6 months postoperatively"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age \u226518 years and \u2264 90 years\n2. Tumor diagnosed as GBM on MRI as assessed by the neurosurgeon\n3. Tumors situated in or near eloquent areas; motor cortex, sensory cortex, subcortical pyramidal tract, speech areas or visual areas as indicated on MRI (Sawaya Grading II and II)\n4. The tumor is suitable for resection (according to neurosurgeon)\n5. Written informed consent\n\nExclusion Criteria:\n\n1. Tumors of the cerebellum, brain stem or midline\n2. Multifocal contrast enhancing lesions\n3. Medical reasons precluding MRI (e.g. pacemaker)\n4. Inability to give written informed consent (e.g. because of severe language barrier)\n5. Second primary malignancy within the past 5 years with the exception of adequately treated in situ carcinoma of any organ or basal cell carcinoma of the skin",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "90 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Adults with primary or recurrent glioblastoma (GBM).",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jasper Gerritsen, MD",
                    "role": "CONTACT",
                    "phone": "+31629119553",
                    "email": "j.gerritsen@erasmusmc.nl"
                },
                {
                    "name": "Arnaud Vincent, MD PhD",
                    "role": "CONTACT",
                    "email": "a.vincent@erasmusmc.nl"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jasper Gerritsen, MD",
                    "affiliation": "Erasmus Medical Center",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California, San Francisco",
                    "status": "NOT_YET_RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mitchel Berger, Dr.",
                            "role": "CONTACT",
                            "email": "mitchel.berger@ucsf.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114-2696",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Brian Nahed, Dr.",
                            "role": "CONTACT",
                            "email": "bnahed@mgh.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "University Hospitals Leuven",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Leuven",
                    "state": "Vlaams-Brabant",
                    "zip": "3000",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Prof. Steven De Vleeschouwer, MD PhD",
                            "role": "CONTACT",
                            "email": "steven.devleeschouwer@uzleuven.be"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.87959,
                        "lon": 4.70093
                    }
                },
                {
                    "facility": "University Hospital Heidelberg",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Heidelberg",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Christine Jungk, Dr. med.",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 49.40768,
                        "lon": 8.69079
                    }
                },
                {
                    "facility": "Technical University Munich",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Munich",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Sandro Krieg, Prof. dr. med.",
                            "role": "CONTACT",
                            "email": "sandro.krieg@tum.de"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.13743,
                        "lon": 11.57549
                    }
                },
                {
                    "facility": "Erasmus MC",
                    "status": "RECRUITING",
                    "city": "Rotterdam",
                    "state": "Zuid-Holland",
                    "zip": "3015 CE",
                    "country": "Netherlands",
                    "contacts": [
                        {
                            "name": "Arnaud Vincent, MD PhD",
                            "role": "CONTACT",
                            "phone": "+31639428949",
                            "email": "a.vincent@erasmusmc.nl"
                        },
                        {
                            "name": "Jasper Gerritsen, MD",
                            "role": "CONTACT",
                            "phone": "+31629119553",
                            "email": "j.gerritsen@erasmusmc.nl"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.9225,
                        "lon": 4.47917
                    }
                },
                {
                    "facility": "Medical Center Haaglanden",
                    "status": "NOT_YET_RECRUITING",
                    "city": "The Hague",
                    "state": "Zuid-Holland",
                    "zip": "2261 CP",
                    "country": "Netherlands",
                    "contacts": [
                        {
                            "name": "Marike Broekman, MD PhD",
                            "role": "CONTACT",
                            "phone": "+31639758253",
                            "email": "m.broekman@haaglandenmc.nl"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.07667,
                        "lon": 4.29861
                    }
                },
                {
                    "facility": "Inselspital Universit\u00e4tsspital Bern",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Bern",
                    "country": "Switzerland",
                    "contacts": [
                        {
                            "name": "Philippe Schucht, Prof. dr. med.",
                            "role": "CONTACT",
                            "email": "philippe.schucht@insel.ch"
                        },
                        {
                            "name": "Kathleen Seidel, Dr. med.",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 46.94809,
                        "lon": 7.44744
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "35569489",
                    "type": "DERIVED",
                    "citation": "Gerritsen JKW, Zwarthoed RH, Kilgallon JL, Nawabi NL, Jessurun CAC, Versyck G, Pruijn KP, Fisher FL, Lariviere E, Solie L, Mekary RA, Satoer DD, Schouten JW, Bos EM, Kloet A, Nandoe Tewarie R, Smith TR, Dirven CMF, De Vleeschouwer S, Broekman MLD, Vincent AJPE. Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study. Lancet Oncol. 2022 Jun;23(6):802-817. doi: 10.1016/S1470-2045(22)00213-3. Epub 2022 May 12."
                },
                {
                    "pmid": "34290067",
                    "type": "DERIVED",
                    "citation": "Gerritsen JKW, Dirven CMF, De Vleeschouwer S, Schucht P, Jungk C, Krieg SM, Nahed BV, Berger MS, Broekman MLD, Vincent AJPE. The PROGRAM study: awake mapping versus asleep mapping versus no mapping for high-grade glioma resections: study protocol for an international multicenter prospective three-arm cohort study. BMJ Open. 2021 Jul 21;11(7):e047306. doi: 10.1136/bmjopen-2020-047306. Erratum In: BMJ Open. 2022 Aug 8;12(8):e047306corr1. doi: 10.1136/bmjopen-2020-047306corr1."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005909",
                    "term": "Glioblastoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001254",
                    "term": "Astrocytoma"
                },
                {
                    "id": "D000005910",
                    "term": "Glioma"
                },
                {
                    "id": "D000018302",
                    "term": "Neoplasms, Neuroepithelial"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9019",
                    "name": "Glioblastoma",
                    "asFound": "Glioblastoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4561",
                    "name": "Astrocytoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M9020",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "M20446",
                    "name": "Neoplasms, Neuroepithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "T2518",
                    "name": "Glioblastoma",
                    "asFound": "Glioblastoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2519",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "asFound": "Function",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}